Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018
USA115th CongressHR-5333| House
| Updated: 7/17/2018
Robert E. Latta
Republican Representative
Ohio
Cosponsors (8)
Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018 This bill amends the Federal Food, Drug, and Cosmetic Act to substantially revise how over-the-counter (OTC) drugs are approved.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Committee Consideration and Mark-up Session Held.
Ordered to be Reported (Amended) by Voice Vote.
Placed on the Union Calendar, Calendar No. 640.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-827.
Mr. Latta moved to suspend the rules and pass the bill, as amended.
Considered under suspension of the rules. (consideration: CR H6227-6237)
DEBATE - The House proceeded with forty minutes of debate on H.R. 5333.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H6227-6235)
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H6227-6235)
Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 518.
Health
Administrative law and regulatory proceduresDrug safety, medical device, and laboratory regulationGovernment studies and investigationsInflation and pricesPrescription drugsUser charges and fees
Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018
USA115th CongressHR-5333| House
| Updated: 7/17/2018
Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018 This bill amends the Federal Food, Drug, and Cosmetic Act to substantially revise how over-the-counter (OTC) drugs are approved.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Committee Consideration and Mark-up Session Held.
Ordered to be Reported (Amended) by Voice Vote.
Placed on the Union Calendar, Calendar No. 640.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-827.
Mr. Latta moved to suspend the rules and pass the bill, as amended.
Considered under suspension of the rules. (consideration: CR H6227-6237)
DEBATE - The House proceeded with forty minutes of debate on H.R. 5333.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H6227-6235)
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H6227-6235)
Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 518.
Robert E. Latta
Republican Representative
Ohio
Cosponsors (8)
Health Subcommittee, Energy and Commerce Committee
Health
Related Bills
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Administrative law and regulatory proceduresDrug safety, medical device, and laboratory regulationGovernment studies and investigationsInflation and pricesPrescription drugsUser charges and fees